GLP3-RT 40mg

GLP3-RT  is a synthetic modified peptide analog supplied as a lyophilized research material for use in qualified laboratory environments. It is intended exclusively for in vitro investigation, analytical characterization, receptor-interaction studies, and controlled assay development involving complex peptide systems. The material is supplied strictly for research use only and is not intended for clinical, therapeutic, diagnostic, human, or veterinary applications.

Product Designation Note:

GLP3-RT  may also be referenced in scientific literature by its investigational designation, LY3437943. The material offered for laboratory research is not represented as an approved pharmaceutical product, finished drug, or therapeutic preparation.

Research Applications:

In controlled non-clinical laboratory settings, GLP3-RT  may be studied for:

• Comparative analysis of multi-receptor peptide interaction profiles
• In vitro receptor-binding and molecular signaling assay development
• Structural characterization and peptide stability evaluation
• Analytical investigation of modified peptide architecture, degradation behavior, and physicochemical properties

All applications are limited to non-human, non-clinical, laboratory-based research systems.

Storage and Handling:

• Store lyophilized material at approximately -20°C under appropriate laboratory conditions.
• Following laboratory reconstitution, maintain at 2-8°C and minimize unnecessary temperature variation.
• Use validated aseptic laboratory procedures and protect the material from contamination, excessive moisture, and repeated freeze-thaw exposure.

Product Specifications:

• Purity: ≥99% when supported by the applicable HPLC analytical report or Certificate of Analysis
• Appearance: Lyophilized white to off-white powder
• Solubility: Soluble in suitable laboratory-grade solvents or buffers according to experimental requirements

Compliance Notice:

GLP3-RT  is supplied FOR RESEARCH USE ONLY as a laboratory and analytical research material. Its structural characteristics correspond to LY3437943, an investigational synthetic peptide designed for research involving GLP-1, GIP, and glucagon receptor systems. It is not an FDA-approved product for any therapeutic indication and must not be used for human or veterinary administration, diagnosis, treatment, prevention, or clinical purposes. The FDA has not independently evaluated the material as a finished research drug product. Purchase and possession are limited to qualified research purposes, and misuse may violate applicable federal, state, or local regulations.